Stocks / INCY

INCY stock forecast

INCYTE CORP · Healthcare · Biotechnology

The model's rating

Greatly Outperform

INCY is rated Greatly Outperform as of November 18, 2026: its medium-term return forecast is in the top fifth of the stocks the model scores.

Unchanged since the rating history began.

Premium adds the numeric score behind this label, the medium-term return forecast, and today's full Upfront Picks.

Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.

INCY is not among the 20 largest holdings published for 2026 Q4. See the portfolio

INCY against the S&P 500

PeriodINCYS&P 500 (SPY)
1 month+4.0%-4.7%
3 months-8.3%-4.8%
Year to date+19.3%+7.9%
1 year+13.4%+11.8%

Total return, dividends included.

Key numbers

Price$117.80
Market cap24.01 Billion
P/E (trailing 12 months)56.4
P/S (trailing 12 months)4.0
P/B (latest quarter)4.2
Gross margin92.7%
Net profit margin6.7%
Return on equity7.1%
Beta0.5

As of October 29, 2026.

INCY and its closest peers

StockCompanyMarket capModel rating
TECH BIO-TECHNE CORP 11.43 Billion Underperform INCY vs TECH
MRNA MODERNA INC 79.63 Billion Greatly Underperform MRNA vs INCY
REGN REGENERON PHARMACEUTICALS INC 97.81 Billion Outperform REGN vs INCY
VRTX VERTEX PHARMACEUTICALS INC 136.01 Billion Outperform VRTX vs INCY

Questions

What does the Upfront Investment model say about INCY?

The model rates INCYTE CORP (INCY) "Greatly Outperform" as of November 18, 2026, which means its medium-term return forecast is in the top fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.

How is the INCY rating produced?

A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.

Is INCY in the Upfront Investment model portfolio?

INCY is not among the 20 largest holdings published for 2026 Q4.

The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.